Literature DB >> 7928631

State of adenomatous polyposis coli gene and ras oncogenes in Japanese prostate cancer.

H Suzuki1, S Aida, S Akimoto, T Igarashi, R Yatani, J Shimazaki.   

Abstract

Genetic alterations of ras oncogenes (K-, H- and N-ras) and adenomatous polyposis coli (APC) gene in tissues of prostate cancer from Japanese patients were examined using PCR-SSCP (polymerase chain reaction-single strand conformation polymorphism) analysis and direct sequencing. Tissues from 8 cases of untreated stage B prostate cancer surgically removed and from 10 cases of endocrine therapy-resistant metastatic disease obtained at autopsy were used in the present study. In four out of 18 cases (22%), ras point mutations were found, two in either codon 12 or 61 of K-ras and two in either 13 or 61 of H-ras. These point mutations were detected in one of the stage B cases (13%) and in three of the autopsy cases (30%). All these cases were poorly differentiated adenocarcinoma. In autopsy cases showing ras mutation in cancerous prostate, the same alteration was observed in metastatic tissues. No APC gene mutation was detected in any sample, although polymorphism was found in some cases. These results indicate that ras oncogene mutations are related to the progression of prostate cancer, whereas APC gene alteration is not involved in tumorigenesis and development of this cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7928631      PMCID: PMC5919564          DOI: 10.1111/j.1349-7006.1994.tb02957.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


adenomatous polyposis coli poly‐merase chain reaction single strand conformation poly‐morphism
  36 in total

1.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.

Authors:  Y Miyoshi; H Ando; H Nagase; I Nishisho; A Horii; Y Miki; T Mori; J Utsunomiya; S Baba; G Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

Review 2.  Carcinoma of the prostate.

Authors:  R F Gittes
Journal:  N Engl J Med       Date:  1991-01-24       Impact factor: 91.245

3.  Improved double-stranded DNA sequencing using the linear polymerase chain reaction.

Authors:  V Murray
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

4.  Localization of the gene for familial adenomatous polyposis on chromosome 5.

Authors:  W F Bodmer; C J Bailey; J Bodmer; H J Bussey; A Ellis; P Gorman; F C Lucibello; V A Murday; S H Rider; P Scambler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

5.  ras gene mutations in human prostate cancer.

Authors:  B S Carter; J I Epstein; W B Isaacs
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

6.  Histochemical examination of expression of ras p21 protein and R 1881-binding protein in human prostatic cancers.

Authors:  H Sumiya; M Masai; S Akimoto; R Yatani; J Shimazaki
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

Review 7.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

8.  The relationship of clinical classification to ras p21 expression in human non-small cell lung cancer.

Authors:  H Dosaka; M Harada; N Kuzumaki; H Kobayashi; H Miyamoto; Y Kawakami
Journal:  Oncology       Date:  1988       Impact factor: 2.935

9.  The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer.

Authors:  A Horii; S Nakatsuru; Y Miyoshi; S Ichii; H Nagase; Y Kato; A Yanagisawa; Y Nakamura
Journal:  Cancer Res       Date:  1992-06-01       Impact factor: 12.701

10.  Appearance of malignant phenotype with partial loss of hormone dependency in androgen-dependent Shionogi Carcinoma 115 transfected with hst-1 gene.

Authors:  Y Furuya; N Sato; Y Watabe; J Shimazaki
Journal:  Jpn J Cancer Res       Date:  1991-11
View more
  10 in total

1.  Recessive oncogenes: current status.

Authors:  Xiang Gao; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

2.  AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion.

Authors:  Seung-Keun Hong; Joseph H Jeong; Andrew M Chan; Jong-In Park
Journal:  Exp Cell Res       Date:  2013-05-20       Impact factor: 3.905

3.  Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma.

Authors:  N Konishi; Y Hiasa; H Matsuda; M Tao; T Tsuzuki; I Hayashi; Y Kitahori; T Shiraishi; R Yatani; J Shimazaki
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

4.  Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation.

Authors:  S Persad; A A Troussard; T R McPhee; D J Mulholland; S Dedhar
Journal:  J Cell Biol       Date:  2001-06-11       Impact factor: 10.539

Review 5.  Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression.

Authors:  Adrian P Rybak; Robert G Bristow; Anil Kapoor
Journal:  Oncotarget       Date:  2015-02-10

6.  PRLTS gene alterations in human prostate cancer.

Authors:  A Komiya; H Suzuki; T Ueda; S Aida; N Ito; T Shiraishi; R Yatani; M Emi; K Yasuda; J Shimazaki; H Ito
Journal:  Jpn J Cancer Res       Date:  1997-04

7.  BRAF activation initiates but does not maintain invasive prostate adenocarcinoma.

Authors:  Joseph H Jeong; Zhenxiong Wang; Alexander S Guimaraes; Xuesong Ouyang; Jose L Figueiredo; Zhihu Ding; Shan Jiang; Isil Guney; Gyeong Hoon Kang; Eyoung Shin; William C Hahn; Massimo F Loda; Cory Abate-Shen; Ralph Weissleder; Lynda Chin
Journal:  PLoS One       Date:  2008-12-16       Impact factor: 3.240

8.  Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer.

Authors:  Y Kawano; S Diez; P Uysal-Onganer; R S Darrington; J Waxman; R M Kypta
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

9.  Mutational analysis of CDKN2 (CDK4I/MTS1) gene in tissues and cell lines of human prostate cancer.

Authors:  A Komiya; H Suzuki; S Aida; R Yatani; J Shimazaki
Journal:  Jpn J Cancer Res       Date:  1995-07

10.  Microsatellite instability and other molecular abnormalities in human prostate cancer.

Authors:  H Suzuki; A Komiya; S Aida; S Akimoto; T Shiraishi; R Yatani; T Igarashi; J Shimazaki
Journal:  Jpn J Cancer Res       Date:  1995-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.